Press Releases

Omeza Receives FDA Clearance for Omeza® Collagen Matrix

Omeza announced today the U.S. Food and Drug Administration (FDA) cleared Omeza® Collagen Matrix through the FDA 510(k) premarket notification process. Omeza® Collagen Matrix is Omeza’s first Rx product, and the first drug/device combination matrix of its kind for chronic wound care.

Omeza Closes on $5MM Bridge Financing

COMPANY IS HEADING TOWARD A $20MM SERIES “A” RAISE Sarasota, Florida 05/010/2021 — Omeza, LLC announced today that it has closed on the sale of $5,000,000 of convertible notes to 22 current …

Read More →

OMEZA Launches second otc Product

Sarasota, FL – 11 09 2020 – Omeza is launching Omeza® Lidocaine Oil, an over the counter (OTC) external analgesic. The product is indicated for temporary relief from pain and itching from …

Read More →